Clinical Trial Update: Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration [NA]

View source ↗

Summary

A completed clinical trial evaluating the use of Dermabond skin adhesive to mitigate spinal cord stimulation lead migration in chronic pain patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Dermabond (2-octyl cyanoacrylate)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Chronic Pain | NA | Status: COMPLETED